These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18332324)

  • 1. The future promise and the current reality of genetic prognostication in patients with uveal melanoma.
    Tsai T; O'Brien JM
    Arch Ophthalmol; 2008 Mar; 126(3):413-5. PubMed ID: 18332324
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytogenetics in the management of uveal melanoma: are we there yet?
    Robertson DM
    Arch Ophthalmol; 2008 Mar; 126(3):409-10. PubMed ID: 18332323
    [No Abstract]   [Full Text] [Related]  

  • 3. Uveal melanoma: prognostication.
    Turell ME; Tubbs RR; Biscotti CV; Singh AD
    Monogr Clin Cytol; 2012; 21():55-60. PubMed ID: 22024584
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular karyotyping for detection of prognostic markers in fine needle aspiration biopsy samples of uveal melanoma.
    Ganguly A; Richards-Yutz J; Ewens KG
    Methods Mol Biol; 2014; 1102():441-58. PubMed ID: 24258992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship.
    Shields CL; Ganguly A; Materin MA; Teixeira L; Mashayekhi A; Swanson LA; Marr BP; Shields JA
    Arch Ophthalmol; 2007 Aug; 125(8):1017-24. PubMed ID: 17698747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens.
    Shields CL; Ganguly A; Bianciotto CG; Turaka K; Tavallali A; Shields JA
    Ophthalmology; 2011 Feb; 118(2):396-401. PubMed ID: 20869116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic, immunohistochemical, and cytogenetic analysis of primary clear cell melanoma of the uvea.
    Verdijk RM; Koopmans AE; Kilic E; Paridaens D; de Klein A
    JAMA Ophthalmol; 2013 Jun; 131(6):814-6. PubMed ID: 23579462
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular prognostic testing in uveal melanoma: has it finally come of age?
    Harbour JW
    Arch Ophthalmol; 2007 Aug; 125(8):1122-3. PubMed ID: 17698762
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research.
    Cook SA; Damato B; Marshall E; Salmon P
    Eye (Lond); 2009 Mar; 23(3):581-5. PubMed ID: 18344957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases.
    Shields CL; Ganguly A; Materin MA; Teixeira L; Mashayekhi A; Swanson LA; Marr BP; Shields JA
    Trans Am Ophthalmol Soc; 2007; 105():43-52; discussion 52-3. PubMed ID: 18427593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveal melanoma: diagnostic features.
    Biscotti CV; Singh AD
    Monogr Clin Cytol; 2012; 21():44-54. PubMed ID: 22024583
    [No Abstract]   [Full Text] [Related]  

  • 12. Instrument Gauge and Type in Uveal Melanoma Fine Needle Biopsy: Implications for Diagnostic Yield and Molecular Prognostication.
    Klofas LK; Bogan CM; Coogan AC; Schultenover SJ; Weiss VL; Daniels AB
    Am J Ophthalmol; 2021 Jan; 221():83-90. PubMed ID: 32818452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens.
    Onken MD; Worley LA; Dávila RM; Char DH; Harbour JW
    J Mol Diagn; 2006 Nov; 8(5):567-73. PubMed ID: 17065425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of advanced genetic testing for clinical prognostication in uveal melanoma.
    Werdich XQ; Jakobiec FA; Singh AD; Kim IK
    Semin Ophthalmol; 2013; 28(5-6):361-71. PubMed ID: 24010756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uveal melanoma: the good and the bad.
    Hadden PW
    Clin Exp Ophthalmol; 2008 Apr; 36(3):203. PubMed ID: 18412585
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic prognostication in uveal melanoma.
    Dogrusöz M; Jager MJ
    Acta Ophthalmol; 2018 Jun; 96(4):331-347. PubMed ID: 29105334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cytogenetics in management of uveal melanoma.
    Shields JA; Shields CL; Materin M; Sato T; Ganguly A
    Arch Ophthalmol; 2008 Mar; 126(3):416-9. PubMed ID: 18332325
    [No Abstract]   [Full Text] [Related]  

  • 18. MOLECULAR PROGNOSTICS FOR UVEAL MELANOMA.
    Seider MI; Mruthyunjaya P
    Retina; 2018 Feb; 38(2):211-219. PubMed ID: 28665870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetics and prognosis for uveal melanoma in Korean patients.
    Lee CS; Lee J; Choi JJ; Yang WI; Yoon JS; Lee SY; Lee SC
    Acta Ophthalmol; 2011 Jun; 89(4):e310-4. PubMed ID: 21310015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genomic techniques used in uveal melanoma: a literature review].
    Abi-Ayad N; Kodjikian L; Couturier J
    J Fr Ophtalmol; 2011 Apr; 34(4):259-64. PubMed ID: 21439677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.